- February 12, 2021
- Category: Food and Beverage, Other Industry Reports
Global Medical Foods Market Size study, by Route of Administration (Oral and Enteral), by Product (Pills, Powder and Others), by Application (Chronic Kidney Disease, Minimal Hepatic Encephalopathy, Chemotherapy Induced Diarrhea, Pathogen Related Infections, Diabetic Neuropathy, ADHD, Depression, Alzheimer's Disease, Nutritional Deficiency, Orphan Diseases and Other), Sales Channel (Online Sales, Retail Sales and Institutional Sales) and Regional Forecasts 2021-2027
Chapter 1.Executive Summary 1.1. Market Snapshot 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion) 1.2.1. Medical Foods Market, by Region, 2019-2027 (USD Billion) 1.2.2. Medical Foods Market, by Route of Administration, 2019-2027 (USD Billion) 1.2.3. Medical Foods Market, by Product, 2019-2027 (USD Billion) 1.2.4. Medical Foods Market, by Application, 2019-2027 (USD Billion) 1.2.5. Medical Foods Market, by Sales Channel, 2019-2027 (USD Billion) 1.2.6. 1.3. Key Trends 1.4. Estimation Methodology 1.5. Research Assumption Chapter 2. Global Medical Foods Market Definition and Scope 2.1. Objective of the Study 2.2. Market Definition & Scope 2.2.1. Scope of the Study 2.2.2. Industry Evolution 2.3. Years Considered for the Study 2.4. Currency Conversion Rates Chapter 3. Global Medical Foods Market Dynamics 3.1. Medical Foods Market Impact Analysis (2019-2027) 3.1.1. Market Drivers 188.8.131.52. Growing prevalence of Alzheimer’s and diabetes 184.108.40.206. Rising geriatric population 3.1.2. Market Restraint 220.127.116.11. Lack of awareness regarding use of medical foods 3.1.3. Market Opportunities 18.104.22.168. Rising investment by market players Chapter 4. Global Medical Foods Market Industry Analysis 4.1. Porter’s 5 Force Model 4.1.1. Bargaining Power of Suppliers 4.1.2. Bargaining Power of Buyers 4.1.3. Threat of New Entrants 4.1.4. Threat of Substitutes 4.1.5. Competitive Rivalry 4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2027) 4.2. PEST Analysis 4.2.1. Political 4.2.2. Economical 4.2.3. Social 4.2.4. Technological 4.3. Investment Adoption Model 4.4. Analyst Recommendation & Conclusion Chapter 5. Global Medical Foods Market, by Route of Administration 5.1. Market Snapshot 5.2. Global Medical Foods Market by Route of Administration, Performance - Potential Analysis 5.3. Global Medical Foods Market Estimates & Forecasts by Route of Administration 2018-2027 (USD Billion) 5.4. Medical Foods Market , Sub Segment Analysis 5.4.1. Oral 5.4.2. Enteral Chapter 6. Global Medical Foods Market, by Product a. Market Snapshot 6.1. Global Medical Foods Market by Product, Performance - Potential Analysis 6.2. Global Medical Foods Market Estimates & Forecasts by Product 2018-2027 (USD Billion) 6.3. Medical Foods Market , Sub Segment Analysis 6.3.1. Pills 6.3.2. Powder 6.3.3. Others Chapter 7. Global Medical Foods Market, by Application b. Market Snapshot 7.1. Global Medical Foods Market by Application, Performance - Potential Analysis 7.2. Global Medical Foods Market Estimates & Forecasts by Application 2018-2027 (USD Billion) 7.3. Medical Foods Market , Sub Segment Analysis 7.3.1. Chronic Kidney Disease 7.3.2. Minimal Hepatic Encephalopathy 7.3.3. Chemotherapy Induced Diarrhea 7.3.4. Pathogen Related Infections 7.3.5. Diabetic Neuropathy 7.3.6. ADHD 7.3.7. Depression 7.3.8. Alzheimer's Disease 7.3.9. Nutritional Deficiency 7.3.10. Orphan Diseases 7.3.11. Other Chapter 8. Global Medical Foods Market, by Sales Channel c. Market Snapshot 8.1. Global Medical Foods Market by Sales Channel, Performance - Potential Analysis 8.2. Global Medical Foods Market Estimates & Forecasts by Sales Channel 2018-2027 (USD Billion) 8.3. Medical Foods Market , Sub Segment Analysis 8.3.1. Online Sales 8.3.2. Retail Sales 8.3.3. Institutional Sales Chapter 9. Global Medical Foods Market, Regional Analysis 9.1. Medical Foods Market , Regional Market Snapshot 9.2. North America Medical Foods Market 9.2.1. U.S. Medical Foods Market 22.214.171.124. Route of Administration breakdown estimates & forecasts, 2018-2027 126.96.36.199. Product breakdown estimates & forecasts, 2018-2027 188.8.131.52. Application breakdown estimates & forecasts, 2018-2027 184.108.40.206. Sales Channel breakdown estimates & forecasts, 2018-2027 9.2.2. Canada Medical Foods Market 9.3. Europe Medical Foods Market Snapshot 9.3.1. U.K. Medical Foods Market 9.3.2. Germany Medical Foods Market 9.3.3. France Medical Foods Market 9.3.4. Spain Medical Foods Market 9.3.5. Italy Medical Foods Market 9.3.6. Rest of Europe Medical Foods Market 9.4. Asia-Pacific Medical Foods Market Snapshot 9.4.1. China Medical Foods Market 9.4.2. India Medical Foods Market 9.4.3. Japan Medical Foods Market 9.4.4. Australia Medical Foods Market 9.4.5. South Korea Medical Foods Market 9.4.6. Rest of Asia Pacific Medical Foods Market 9.5. Latin America Medical Foods Market Snapshot 9.5.1. Brazil Medical Foods Market 9.5.2. Mexico Medical Foods Market 9.6. Rest of The World Medical Foods Market Chapter 10. Competitive Intelligence 10.1. Top Market Strategies 10.2. Company Profiles 10.2.1. Danone 10.2.1.1. Key Information 10.2.1.2. Overview 10.2.1.3. Financial (Subject to Data Availability) 10.2.1.4. Product Summary 10.2.1.5. Recent Developments 10.2.2. Nestle Nutrition 10.2.3. Abbott Nutrition 10.2.4. Targeted Medical Pharma Inc. 10.2.5. Primus Pharmaceuticals Inc. 10.2.6. Mead Johnson & Company, LLC 10.2.7. Medtrition Inc. 10.2.8. Fresenius Kabi AG 10.2.9. Reckitt Benckiser Group plc 10.2.10. Metagenics, Inc. Chapter 11. Research Process 11.1. Research Process 11.1.1. Data Mining 11.1.2. Analysis 11.1.3. Market Estimation 11.1.4. Validation 11.1.5. Publishing 11.2. Research Attributes 11.3. Research Assumption
Global Medical Foods Market is valued approximately at USD 20.15 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 5.2% over the forecast period 2021-2027. Medical foods are principally formulated foods, that are taken orally or by tube under the supervision of health professionals to provide the nutrients to patients not present in a normal diet, for the management of diseases such as Alzheimer’s, nutritional deficiency, depression and others. Increasing prevalence of malnutrition, Alzheimer’s and diabetes, growing geriatric population, and continuous innovation medical foods are leading the market towards growth. For instance, according to USA Against Alzheimer’s report of 2021, about 6.2 million people in United States are living with Alzheimer’s, and by 2050, 2.7 million Americans 65 and older will have Alzheimer’s. Also, according to International Diabetes Foundation, in 2019, 463 million people worldwide were living with diabetes which is expected to reach 578 million by 2030. Furthermore, growing investments by market players in form of mergers, acquisitions, research and development and others are expected to boost the demand in coming years. However, lack of awareness regarding use of medical foods may hamper the growth during forecast period.
Asia Pacific, North America, Europe, Latin America, and Rest of the World are considered for the regional analysis of the global Medical Foods Market. North America is the dominating region across the world in terms of market share due to growing awareness regarding medical foods and increasing problem of Alzheimer’s disease. Whereas Asia pacific is anticipated to exhibit the highest growth rate over the forecast period 2021-2027 due to improved education towards medical foods and continuous innovation.
Major market player included in this report are:
Targeted Medical Pharma Inc.
Primus Pharmaceuticals Inc.
Mead Johnson & Company, LLC
Fresenius Kabi AG
Reckitt Benckiser Group plc
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Route of Administration:
Chronic Kidney Disease
Minimal Hepatic Encephalopathy
Chemotherapy Induced Diarrhea
Pathogen Related Infections
By Sales Channel:
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2018, 2019
Base year – 2020
Forecast period – 2021 to 2027.
Target Audience of the Global Medical Foods Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Value-Added Resellers (VARs)
Third-party knowledge providers